4029 POSTER Phase II clinical trial of metronomic cyclophosphamide (CTX) plus celecoxib (C) and dexamethasone (DEX) in advanced hormone refractory prostate cancer (HRPC): preliminary clinical and pharmacodynamic results
A. Fontana, G. Bocci, L. Galli, E. Fontana, C. Galli, L. Landi, A. Fioravanti, R. Di Marsico, M. Del Tacca, A. FalconeТом:
5
Рік:
2007
Мова:
english
DOI:
10.1016/s1359-6349(07)71097-2
Файл:
PDF, 61 KB
english, 2007